Penumbra Inc.

272.77
12.14 (4.66%)
At close: Mar 14, 2025, 3:59 PM
273.75
0.36%
After-hours: Mar 14, 2025, 06:20 PM EDT
4.66%
Bid 272.5
Market Cap 10.51B
Revenue (ttm) 1.19B
Net Income (ttm) 13.97M
EPS (ttm) 0.36
PE Ratio (ttm) 757.69
Forward PE 71.39
Analyst Buy
Ask 274
Volume 267,698
Avg. Volume (20D) 470,466
Open 266.46
Previous Close 260.63
Day's Range 266.24 - 274.63
52-Week Range 148.00 - 310.00
Beta 0.51

About PEN

Penumbra, Inc. designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers aspiration based thrombectomy systems and accessory devices, including revascularization device for mechanical thrombectomy, such as Penumbra System under the Penumbra RED, JET, ACE, 3D Revascularization Device, and Penumbra ENGINE brands, as well as components and accessories; neurovascular embolization coiling...

Sector Healthcare
IPO Date Sep 18, 2015
Employees 4,500
Stock Exchange NYSE
Ticker Symbol PEN
Full Company Profile

Analyst Forecast

According to 16 analyst ratings, the average rating for PEN stock is "Buy." The 12-month stock price forecast is $305, which is an increase of 11.82% from the latest price.

Stock Forecasts

Next Earnings Release

Penumbra Inc. is scheduled to release its earnings on May 6, 2025, during market hours.
Analysts project revenue of ... Unlock content with Pro Subscription
1 day ago
Penumbra shares are trading higher after B of A Se... Unlock content with Pro Subscription
3 weeks ago
+12.03%
Penumbra shares are trading higher after Baird and Morgan Stanley raised their respective price targets on the stock.